Vaccine effectiveness of COVID-19 and rebound in the real world

被引:0
作者
Myung-Bae Park
Boram Sim
机构
[1] Pai Chai University,Department of Health and Welfare
[2] HIRA Research Institute,undefined
[3] Health Insurance Review and Assessment Service (HIRA),undefined
来源
Clinical and Experimental Medicine | 2023年 / 23卷
关键词
COVID-19; SARS-CoV-2; Vaccines; Rebound; Mortality;
D O I
暂无
中图分类号
学科分类号
摘要
We intend to evaluate the relationship between the rates of global SARS-CoV-2 vaccination and the number of COVID-19 confirmed cases, as well as the mortality rate after the declaration of a pandemic. Of the data from 191 countries at the time of data retraction, we selected 111 countries that have SARS-CoV-2 vaccination reports. We stratified countries into high-income and non-high-income countries (HIC and non-HIC) based on World Bank income-group. We used a fixed-effects model (FEM) and performed a longitudinal analysis. The number of confirmed cases decreased as the vaccination rates increased in both non-HICs (B =  − 0.027, T =  − 2.0) and HICs (B =  − 0.207, T =  − 17.5). The number of deaths decreased as the vaccination rates increased in both non-HICs (B =  − 0.151, T =  − 2.3) and HICs (B =  − 0.230, T =  − 40.9). For full vaccination, this measure had a negative association with daily confirmed cases and daily deaths in both non-HICs and HICs. In non-HICs, daily cases and daily deaths decreased as the first vaccination and full vaccination coverages increased. However in HICs, daily cases and daily deaths decreased as the first vaccination and full vaccination coverages increased in the early phase, but after a certain period, they tended to increase again. We observed a significant association between the increase in vaccination coverage in the real world and reduced daily confirmed cases and deaths. However, as the confirmed cases and deaths have rebounded in HICs, our findings indicate that COVID-19 is not completely prevented through vaccine distribution.
引用
收藏
页码:4975 / 4983
页数:8
相关论文
共 50 条
[41]   Assessing COVID-19 Vaccine Effectiveness and Risk Factors for Severe Outcomes through Machine Learning Techniques: A Real-World Data Study in Andalusia, Spain [J].
Serrano-Ortiz, Alvaro ;
Romero-Cabrera, Juan Luis ;
Monserrat Villatoro, Jaime ;
Cordero-Ramos, Jaime ;
Ruiz-Montero, Rafael ;
Ritore, Alvaro ;
Dopazo, Joaquin ;
del Diego Salas, Jorge ;
Garcia Sanchez, Valle ;
Salcedo-Leal, Inmaculada ;
Armengol de la Hoz, Miguel angel ;
Tunez, Isaac ;
Guzman, Miguel angel .
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2024, 14 (04) :1504-1517
[42]   Effectiveness and Safety of COVID-19 Vaccine among Pregnant Women in Real-World Studies: A Systematic Review and Meta-Analysis [J].
Ma, Yirui ;
Deng, Jie ;
Liu, Qiao ;
Du, Min ;
Liu, Min ;
Liu, Jue .
VACCINES, 2022, 10 (02)
[43]   Correlation between vaccine coverage and the COVID-19 pandemic throughout the world: Based on real-world data [J].
Huang, Chao ;
Yang, Lijun ;
Pan, Jia ;
Xu, Xiaomei ;
Peng, Rong .
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) :2181-2187
[44]   Considerations and guidance to control the rebound in COVID-19 cases [J].
Li, Qian ;
Zhan, Xiangming ;
Wang, Jun ;
Lu, Hongzhou .
BIOSCIENCE TRENDS, 2021, 15 (05) :341-344
[45]   Ethics and Effectiveness of US COVID-19 Vaccine Mandates and Vaccination Passports: A Review [J].
Canning, Alexa G. ;
Watson, Kyleigh E. ;
McCreedy, Katelyn E. ;
Olawepo, John O. .
JOURNAL OF RESEARCH IN HEALTH SCIENCES, 2022, 22 (02)
[46]   Factors Predicting COVID-19 Vaccine Effectiveness and Longevity of Humoral Immune Responses [J].
Berber, Engin ;
Ross, Ted M. .
VACCINES, 2024, 12 (11)
[47]   Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States [J].
Layton, J. Bradley ;
Peetluk, Lauren ;
Wong, Hui Lee ;
Jiao, Yixin ;
Djibo, Djeneba Audrey ;
Bui, Christine ;
Lloyd, Patricia C. ;
Gruber, Joann F. ;
Miller, Michael ;
Ogilvie, Rachel P. ;
Deng, Jie ;
Parambi, Ron ;
Song, Jennifer ;
Weatherby, Lisa B. ;
Lo, An-Chi ;
Matuska, Kathryn ;
Wernecke, Michael ;
Clarke, Tainya C. ;
Cho, Sylvia ;
Bell, Elizabeth J. ;
Seeger, John D. ;
Yang, Grace Wenya ;
Illei, Dora ;
Forshee, Richard A. ;
Anderson, Steven A. ;
McMahill-Walraven, Cheryl N. ;
Chillarige, Yoganand ;
Amend, Kandace L. ;
Anthony, Mary S. ;
Shoaibi, Azadeh .
VACCINE: X, 2024, 16
[48]   Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy [J].
Vasilev, Georgi ;
Kabakchieva, Plamena ;
Miteva, Dimitrina ;
Batselova, Hristiana ;
Velikova, Tsvetelina .
WORLD JOURNAL OF DIABETES, 2022, 13 (09) :738-751
[49]   Nirmatrelvir treatment duration and frequency of COVID-19 rebound [J].
Sudeep, Nathan ;
Kojima, Noah ;
Klausner, Jeffrey D. .
ANTIVIRAL THERAPY, 2025, 30 (01)
[50]   COVID-19 Vaccine Effectiveness Against Progression to In-Hospital Mortality in Zambia, 2021-2022 [J].
Chanda, Duncan ;
Hines, Jonas Z. ;
Itoh, Megumi ;
Fwoloshi, Sombo ;
Minchella, Peter A. ;
Zyambo, Khozya D. ;
Sivile, Suilanji ;
Kampamba, Davies ;
Chirwa, Bob ;
Chanda, Raphael ;
Mutengo, Katongo ;
Kayembe, Mazinga F. ;
Chewe, Webster ;
Chipimo, Peter ;
Mweemba, Aggrey ;
Agolory, Simon ;
Mulenga, Lloyd B. .
OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (09)